Synthetic Surgery ApS: Financial statements 2025
CVR: 44696363
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Synthetic Surgery ApS (CVR 44696363) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -8,029 and a net result of DKK -9,940. Equity in the 2025 report amounted to DKK 11,957. The solvency ratio was 9.6%.
- Gross Profit
- DKK -8,029
- Profit/Loss
- DKK -9,940
- Equity
- DKK 11,957
- Total Assets
- DKK 124,157
- Employees
- 0
Official annual report
How creditworthy is Synthetic Surgery ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Synthetic Surgery ApS has published its interim report for the period March 8, 2024 to December 31, 2024.
About Synthetic Surgery ApS
Synthetic Surgery ApS is a Danish company of the type Anpartsselskab based in Haderslev, founded in 2024. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Mads Monrad, Morten Bo Søndergaard Svendsen and Peter Hertz. The company is owned by MMN HOLDING ApS, Bigbait Holding ApS and PH Medical Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -8,029 and a net result of DKK -9,940. Equity in the 2025 report amounted to DKK 11,957.